CME Group: The Bull Case Remains Compelling
Summary
CME Group shares have returned 19% since my previous Buy recommendation, driven by multiple expansion and an increase in...
CME Group shares have returned 19% since my previous Buy recommendation, driven by multiple expansion and an increase in consensus earnings estimates. CME's business fundamentals remain strong, and the company is well positioned to benefit from increasing financial market volatility in the future. CME stock has experienced a modest degree of multiple expansion but continues to trade at attractive levels.